FDA clears Smiths Medical's at-home ambulatory care unit
February 14, 2013 by MassDevice staff
The FDA gives Smiths Medical the OK to launch its Cadd-Solis ambulatory care system in the U.S.
St. Paul, Minn,-based device maker Smiths Medical got the green-light from the FDA for its newest ambulatory infusion system, which has been approved for at-home use.
The Cadd-Solis VIP ambulatory infusion system integrates some of Smith Medical's other products, including its infusion pump, medication-level monitoring system and medication reservoirs
Sign up to get our free newsletters delivered right to your inbox.
"The new Cadd-Solis VIP system provides enhanced safety features and convenience for healthcare providers who want to provide optimal care for their infusion patients in the home," CEO Srini Seshadri said in a press release.
Earlier this month, MassDevice.com reported that Smiths Medical sold 23 U.S. patents to Tandem Diabetes Care. That sale included the licenses for all future product development in ambulatory infusion pumps and all related accessories and software, according to a statement by Tandem Diabetes Care.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Diabetes: Abbott's glucose monitor software glitch gets FDA's highest-risk recall
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
Weight loss: GI Dynamics' U.S. clinical trial taxes its coffers
Weight-loss devices maker GI Dynamics tells investors today that the company may seek new funding as...
Medtronic touts European win for Export Advance aspiration catheter
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent...
Covidien restates Q2 financials ahead of pharma spinout | Wall Street Beat
Covidien restates its financial results for its fiscal 2nd quarter ahead of the spinout of its...
Can the FDA keep its user fee promises amid sequester?
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from...
